Daniel Morgensztern
Impact in
- Oncology top 0.2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 98
- Lung Cancer Research Studies 53
- Cancer Immunotherapy and Biomarkers 24
-
- Lung Cancer Treatments and Mutations 66
- Lung Cancer Diagnosis and Treatment 34
- Co-authors
- Roy S. Herbst (11 shared papers)CHRIS H. BOSHOFF (1 shared paper)Ramaswamy Govindan (68 shared papers)Saiama Naheed Waqar (46 shared papers)Jay F. Piccirillo (2 shared papers)Feng Ying Gao (15 shared papers)Howard L. McLeod (1 shared paper)Nathan C. Page (1 shared paper)
- Journals
- Journal of Thoracic Oncology (33 papers)Annals of Oncology (15 papers)Journal of Clinical Oncology (13 papers)Journal of the National Comprehensive Cancer Network (11 papers)Clinical Lung Cancer (9 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Daniel Morgensztern
198 papers receiving 15.2k citations
Daniel Morgensztern's Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 6.1k
- Pulmonary and Respiratory Medicine 5.3k
- Cancer Research 2.1k
- Molecular Biology 4.0k
- Epidemiology 1.8k
Countries citing papers authored by Daniel Morgensztern
This map shows the geographic impact of Daniel Morgensztern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Morgensztern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Morgensztern more than expected).
Fields of papers citing papers by Daniel Morgensztern
This network shows the impact of papers produced by Daniel Morgensztern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Morgensztern. The network helps show where Daniel Morgensztern may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Morgensztern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The biology and management of non-small cell lung cancer Hit paper breakdown → | 2018 | 3607 |
| 2 | Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database Hit paper breakdown → | 2006 | 1562 |
| 3 | Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 1007 |
| 4 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 Hit paper breakdown → | 2021 | 756 |
| 5 | Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas Hit paper breakdown → | 2017 | 491 |
| 6 | Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study Hit paper breakdown → | 2016 | 468 |
| 7 | Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey Hit paper breakdown → | 2010 | 445 |
| 8 | Non–Small Cell Lung Cancer, Version 4.2024 Hit paper breakdown → | 2024 | 423 |
| 9 | 2005 | 409 | |
| 10 | NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023 Hit paper breakdown → | 2023 | 339 |
| 11 | 2015 | 324 | |
| 12 | 2019 | 271 | |
| 13 | 2018 | 223 | |
| 14 | 2021 | 215 | |
| 15 | 2006 | 203 | |
| 16 | 2014 | 197 | |
| 17 | 2015 | 192 | |
| 18 | 2018 | 183 | |
| 19 | 2010 | 170 | |
| 20 | 2017 | 156 |
About Daniel Morgensztern
Daniel Morgensztern is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 208 papers that have together received 15.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (66 papers), Lung Cancer Research Studies (53 papers), Lung Cancer Diagnosis and Treatment (34 papers), Cancer Immunotherapy and Biomarkers (24 papers), Cancer Genomics and Diagnostics (22 papers), Lymphoma Diagnosis and Treatment (18 papers), Neuroendocrine Tumor Research Advances (14 papers) and Cancer therapeutics and mechanisms (11 papers). The work is most often cited by research in Oncology (6.1k citations), Pulmonary and Respiratory Medicine (5.3k citations), Cancer Research (2.1k citations), Molecular Biology (4.0k citations) and Epidemiology (1.8k citations). Daniel Morgensztern has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Roy S. Herbst, CHRIS H. BOSHOFF, Ramaswamy Govindan, Saiama Naheed Waqar, Jay F. Piccirillo, Feng Ying Gao, Howard L. McLeod, Nathan C. Page, Ryan M. Tierney and Anna Vlahiotis. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Journal of Clinical Oncology, Journal of the National Comprehensive Cancer Network and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.